Jean-François Formela, M.D.

Jean-François Formela is a partner and focuses on novel drug discovery approaches and therapeutics. He joined Atlas Venture in 1993 to build the U.S. life sciences franchise.

He is a director and co-founder of IFM Therapeutics, Intellia Therapeutics, Korro Bio, and Triplet Therapeutics. Jean-François also serves on the boards of Ikena Oncology and Scorpion Therapeutics.
Some of his prior investments include Adnexus (acquired by BMS), Arteaus Therapeutics (acquired by Eli Lilly), CoStim Pharmaceuticals (acquired by Novartis), Exelixis and Translate Bio (acquired by Sanofi).

Jean-François received his M.D. from Paris University School of Medicine and his M.B.A. from Columbia University.